We are live on
!
Find out more
TCP
Tyndall Capital Partners Portfolio holdings
AUM
$452K
1-Year Est. Return
26.52%
This Fund
S&P 500
This Quarter
Est. Return
+16.4%
1 Year Est. Return
+26.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$452K
AUM Growth
+$39.7K
(+9.6%)
Cap. Flow
-$28.6K
Cap. Flow
% of AUM
-6.34%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cyclerion Therapeutics
CYCN
|
+$28.6K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
CCM
HIP
BPWM
NP
CP
AI
CAWM
ADIM
Tyndall Capital Partners's Q2 2025 Portfolio in Review
As of Q2 2025, Tyndall Capital Partners held 1 position worth $452K, up 9.6% from $412K the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Tyndall Capital Partners withdrew a net $28.6K in Q2 2025, reducing 1 holding. Its largest reduction was Cyclerion Therapeutics, cutting an estimated $28.6K.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Tyndall Capital Partners's biggest Q2 2025 reduction was Cyclerion Therapeutics, cutting an estimated $28.6K.
- Tyndall Capital Partners's ten largest holdings make up 100% of its $452K portfolio in Q2 2025.
- Tyndall Capital Partners opened 0 new positions and closed 0 in Q2 2025.
- Tyndall Capital Partners's portfolio value rose 9.6% quarter-over-quarter to $452K.
Based on Tyndall Capital Partners's 13F filing for Q2 2025, filed 14 Aug 2025.